Bakkafrost swings to Q1 profit, lifts Faroes harvest outlook

Bakkafrost reported Q1 EBIT of 544 million Danish crowns, up from 505 million a year earlier, and returned to a 307 million crown net profit versus a 6 million crown loss. Revenue rose 11% to 2.11 billion crowns on a 24% increase in harvested volumes to 31,337 tonnes, and the company lifted its 2026 Faroe Islands harvest guidance to about 97,000 tonnes from 92,000 tonnes. Results were partly offset by weaker salmon prices and a Scottish farming loss of 63 million crowns, making the overall read mixed but constructive.

Analysis

This print is less about a single-good quarter and more about a widening strategic gap inside the same franchise: the Faroe Islands are increasingly the engine of earnings while Scotland is behaving like a capital sink. That matters because the market typically values salmon names on near-term EPS, but the real driver of multiple expansion is confidence in sustainable biomass growth and mortality control; the raised Faroes outlook should support forward estimates, while Scotland keeps a ceiling on how much of that improvement can be capitalized.

The second-order effect is on supply, not just this company. A step-up in expected 2026 harvests from a relatively efficient geography adds incremental Atlantic salmon supply into a market already sensitive to biological resets, which argues against a sharp price recovery even if Chinese demand stays resilient. In other words, better company execution can still be bearish for industry pricing: the better Bakkafrost gets at farming, the more it reinforces a lower-for-longer price environment for the broader Nordic basket.

The key risk is timing. Over the next 1-2 quarters, the market may reward the earnings inflection and ignore the pricing headwind, but over 6-12 months the realized benefit depends on whether the Faroe uplift is repeatable without a corresponding deterioration in harvest prices. The tail risk is Scotland: if biological issues persist, it can offset most of the Faroes upside and force the market to re-rate the story as a high-quality core asset surrounded by a structurally weaker satellite business.

Key Decisions for Investors

• Long BAKKA on pullbacks for a 3-6 month trade: the raised Faroes guidance improves visibility and should support estimate revisions, but size modestly because Scotland creates a recurring drag; target a 10-15% upside with a tight stop if salmon price indicators weaken further.
• Pair trade: long BAKKA / short a higher-beta salmon producer with more leverage to spot prices for a 1-2 quarter horizon. The thesis is that Bakkafrost’s mix shift toward better biological performance is more durable than pure price exposure, while the short leg absorbs industry price compression.
• Short the broader salmon basket on strength via Norway-linked producers if spot prices rally into the next volume window. The incremental supply implication from 2026 guidance makes any near-term price bounce vulnerable to fade within 2-4 months.
• Avoid chasing calls on salmon names into earnings revisions unless Scotland stabilizes. The cleaner expression is to own operational winners with geographic diversification; otherwise the trade is hostage to one adverse biological event.